New product: Prevymis (letermovir) concentrate for solution for infusion

Letermovir is licensed for prophylaxis of cytomegalovirus reactivation and disease in adult cytomegalovirus-seropositive recipients of an allogeneic haematopoietic stem cell transplant.

electronic Medicines compendium